Visual symptoms after COVID-19 suggest retinal involvement

Article

Investigators advised that clinicians should be aware of this spectrum of retinal involvement after COVID-19 infections and emphasized the importance of a fundus evaluation.

Visual symptoms after COVID-19 suggest retinal involvement

Retinal involvement following a COVID-19 infection is rare but can happen after severe infections in immunocompetent individuals, according to Dr Yusar Asad and colleagues from the Vitreoretinal Services, Centre for Sight, Delhi, India.

The research team conducted a retrospective review of consecutive patients presenting with retinal manifestations attributable to COVID-19 between May 2020 and June 2021.

The study included 20 eyes of 17 patients. All COVID-19 infections were confirmed by reverse transcriptase polymerase chain reaction. All other causes of retinal involvement were eliminated by systemic work-ups.

Dr Asad reported that the patients presented with vascular involvement such as venous stasis retinopathy, central retinal vein occlusion (unilateral/bilateral), branch retinal artery occlusion, and anterior ischemic optic neuropathy as well as opportunistic infections like endogenous endophthalmitis, candidemia retinitis, and subretinal abscess in orbital mucormycosis.

“A whole spectrum of manifestations following COVID-19 infections in an otherwise immunocompetent patient presenting at a tertiary care centre have been documented,” the investigators reported.

They advised that clinicians should be aware of this spectrum of retinal involvement after COVID-19 infections and emphasized the importance of a fundus evaluation. “While it is rare, it is important that these diseases can develop in a patient with visual symptoms,” Dr Asad commented.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.